https://orcid.org/0000-0003-4534-4248
Citations (93)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Razan Mohty, Yenny Moreno Vanegas, Julio C. Chavez & Mohamed A. Kharfan-Dabaja. (2023) Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma. Expert Review of Anticancer Therapy 23:2, pages 121-126.
Read now
Read now
Othman Mohammad Saleh, Khaled Anwer Albakri, Yasmeen Jamal Alabdallat, Majd Hamdi Dajani & Walaa Bayoumie El Gazzar. (2022) The safety and efficacy of CAR-T cells in the treatment of prostate cancer: review. Biomarkers 27:1, pages 22-34.
Read now
Read now
Ajay Major, Jennifer Collins, Caroline Craney, Alisa K. Heitman, Emily Bauer, Elizabeth Zerante, Wendy Stock, Michael R. Bishop & Jagoda Jasielec. (2021) Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature. Leukemia & Lymphoma 62:7, pages 1765-1769.
Read now
Read now
Marwan M. Azar, Junghee J. Shin, Insoo Kang & Marie Landry. (2020) Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Expert Review of Molecular Diagnostics 20:11, pages 1087-1097.
Read now
Read now
Articles from other publishers (89)
S. Fizza Haider, R. Sloss, S. Jhanji, E. Nicholson & B. Creagh‐Brown. (2023) Management of adult patients with haematological malignancies in critical care. Anaesthesia 78:7, pages 874-883.
Crossref
Crossref
Ifeyinwa Obiorah & Elizabeth L. Courville. (2023) Diagnostic Flow Cytometry in the Era of Targeted Therapies. Surgical Pathology Clinics 16:2, pages 423-431.
Crossref
Crossref
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, Summya Rashid, Muhammad Omer Iqbal, Renata Kontek, Muhanad A. Abdulsamad & Abdulmutalib A. Allaq. (2023) Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. Cancers 15:10, pages 2721.
Crossref
Crossref
Rujul H. Parikh & Sagar Lonial. (2023) Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice. CA: A Cancer Journal for Clinicians 73:3, pages 275-285.
Crossref
Crossref
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, Miao Li, Pin Wang & Lili Yang. (2023) Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell 30:5, pages 592-610.
Crossref
Crossref
Karan L. Chohan, Elizabeth L. Siegler & Saad S. Kenderian. (2023) CAR-T Cell Therapy: the Efficacy and Toxicity Balance. Current Hematologic Malignancy Reports 18:2, pages 9-18.
Crossref
Crossref
Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, Adam Kramer, Yichen Zhu, Niels Dawson & Lili Yang. (2023) Mucosal-associated invariant T cells for cancer immunotherapy. Molecular Therapy 31:3, pages 631-646.
Crossref
Crossref
John K Muthuka, Kelly Oluoch, Francis M Wambura, Japheth M Nzioki & Rosemary Nabaweesi. (2023) HIV and Associated Indicators of COVID-19 Cytokine Release Syndrome: A Meta-Analysis and Meta-Regression. Cureus.
Crossref
Crossref
Erika Yue Lee & Baruch D. Jakubovic. (2023) Interleukin-6 and cytokine release syndrome. Annals of Allergy, Asthma & Immunology 130:2, pages 178-184.
Crossref
Crossref
Hee Young Kang, Soo Yun Lee, Hyun Min Kim, Su Ui Lee, Hyunseung Lee, Mi Young Cho, Se-Chan Oh, Seok-Min Kim, Hye Sun Park, Eun Hee Han, Seong-Eun Kim, Hyori Kim, Suk Ran Yoon, Junsang Doh, Junho Chung, Kwan Soo Hong, Inpyo Choi & Tae-Don Kim. (2023) A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets. Frontiers in Immunology 13.
Crossref
Crossref
Johan Engström. 2023. ELISA. ELISA
109
127
.
Madhusudhan Umesh, Vidya Singaravelu, Vandana Daulatabad, Prafull Kamble, Anish Singhal, Nitin Ashok John & Jyoti John. (2022) An overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelae. Hormone Molecular Biology and Clinical Investigation 43:4, pages 475-484.
Crossref
Crossref
Yago Alcaina, Yanping Yang, Yogindra Vedvyas, Jaclyn E. McCloskey & Moonsoo M. Jin. (2022) SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity. Scientific Reports 12:1.
Crossref
Crossref
Matthew Foster, Yonatan Negash, Leslie Eberhardt, Wilson W. Bryan, Kimberly Schultz, Xiaofei Wang, Yuan Xu & Bindu George. (2022) Cross-study safety analysis of risk factors in CAR T cell clinical trials: An FDA database pilot project. Molecular Therapy - Oncolytics 27, pages 182-194.
Crossref
Crossref
Letizia Vitali, Alessandra Merlini, Federica Galvagno, Alessia Proment & Dario Sangiolo. (2022) Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19. Biomedicines 10:10, pages 2628.
Crossref
Crossref
Dori R. Germolec, Herve Lebrec, Stacey E. Anderson, Gary R. Burleson, Andres Cardenas, Emanuela Corsini, Sarah E. Elmore, Barbara L.F. Kaplan, B. Paige Lawrence, Geniece M. Lehmann, Curtis C. Maier, Cliona M. McHale, L. Peyton Myers, Marc Pallardy, Andrew A. Rooney, Lauren Zeise, Luoping Zhang & Martyn T. Smith. (2022) Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification. Environmental Health Perspectives 130:10.
Crossref
Crossref
Hazim S. Ababneh, Jeremy S. Abramson, P. Connor Johnson & Chirayu G. Patel. (2022) Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy. Radiotherapy and Oncology 175, pages 65-72.
Crossref
Crossref
Dimitrios C. Arhontoulis, Charles M. Kerr, Dylan Richards, Kelsey Tjen, Nathaniel Hyams, Jefferey A. Jones, Kristine Deleon‐Pennell, Donald Menick, Hanna Bräuninger, Diana Lindner, Dirk Westermann & Ying Mei. (2022) Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries. Journal of Tissue Engineering and Regenerative Medicine 16:9, pages 799-811.
Crossref
Crossref
Antonio Nenna, Myriam Carpenito, Camilla Chello, Pierluigi Nappi, Ombretta Annibali, Bruno Vincenzi, Francesco Grigioni, Massimo Chello & Francesco Nappi. (2022) Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment. International Journal of Molecular Sciences 23:15, pages 8242.
Crossref
Crossref
Mark D. Stewart, Bruce McCall, Marcelo Pasquini, Allen S. Yang, Carolyn D. Britten, Meredith Chuk, R Angelo De Claro, Bindu George, Nicole Gormley, Mary M. Horowitz, Eric Kowack, Candice McCoy, Phuong Khanh Morrow, Emmanuel Okoye, Rosanna Ricafort, John Rossi, Elad Sharon, Marc Theoret, Ferdinando Vegni, Tai Yu & Jeff Allen. (2022) Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials. Cytotherapy 24:7, pages 742-749.
Crossref
Crossref
Harish Sudarsanam, Raymund Buhmann & Reinhard Henschler. (2022) Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Ajeet Gajra, Abigail Zalenski, Aishwarya Sannareddy, Yolaine Jeune-Smith, Kandice Kapinos & Ankit Kansagra. (2022) Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice. Pharmaceutical Medicine 36:3, pages 163-171.
Crossref
Crossref
Mohaddeseh Bahmani, Rojin Chegini, Elham Ghanbari, Elham Sheykhsaran, Parisa Shiri Aghbash, Hamed Ebrahimzadeh Leylabadlo, Ehsan Moradian, Amir Masoud Kazemzadeh Houjaghan & Hossein Bannazadeh Baghi. (2022) Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade. World Journal of Virology 11:3, pages 113-128.
Crossref
Crossref
B Čemusová. (2022) Cytokine release syndrome after CAR T-cell therapy: a review of the literature and our experience. Anesteziologie a intenzivní medicína 33:2, pages 90-96.
Crossref
Crossref
Mehran Ghasemzadeh, Javad Ahmadi & Ehteramolsadat Hosseini. (2022) Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?. Thrombosis Research 213, pages 179-194.
Crossref
Crossref
Lei Fan, Li Wang, Lei Cao, Huayuan Zhu, Wei Xu & Jianyong Li. (2021) Phase I study of CBM.CD19 chimeric antigen receptor T cell in the treatment of refractory diffuse large B-cell lymphoma in Chinese patients. Frontiers of Medicine 16:2, pages 285-294.
Crossref
Crossref
Gianluca Selvaggio, Silvia Parolo, Pranami Bora, Lorena Leonardelli, John Harrold, Khamir Mehta, Dan A. Rock & Luca Marchetti. (2022) Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model. Frontiers in Oncology 12.
Crossref
Crossref
Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi, Michael Weller, Amy B. Heimberger & Mustafa Khasraw. (2022) Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma. Clinical Cancer Research 28:4, pages 585-593.
Crossref
Crossref
Hisham Abdel-Azim, Hema Dave, Kimberly Jordan, Stephanie Rawlings-Rhea, Annie Luong & Ashley L. Wilson. (2022) Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy. Cytotherapy 24:2, pages 193-204.
Crossref
Crossref
Yeonsun Hong & In-San Kim. (2022) The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer. BMB Reports 55:1, pages 39-47.
Crossref
Crossref
Wenyujing Zhou, Weihong Chen, Xiaochun Wan, Changru Luo, Xin Du, Xiaoqing Li, Qian Chen, Ruiwen Gao, Xiaohan Zhang, Mei Xie & Mingjun Wang. (2022) Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma. Frontiers in Genetics 12.
Crossref
Crossref
Christian Zanza, Tatsiana Romenskaya, Alice Chiara Manetti, Francesco Franceschi, Raffaele La Russa, Giuseppe Bertozzi, Aniello Maiese, Gabriele Savioli, Gianpietro Volonnino & Yaroslava Longhitano. (2022) Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina 58:2, pages 144.
Crossref
Crossref
Federico Rodríguez Quezada. (2022) Terapias novedosas: CAR-T aspectos prácticos y aplicación clínica. Revista Mexicana de Medicina Transfusional 14:S1, pages s43-46.
Crossref
Crossref
Razan Mohty & Mohamed A. Kharfan-Dabaja. (2022) CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma. Therapeutic Advances in Hematology 13, pages 204062072211421.
Crossref
Crossref
Yunjung H Shin, Xiaofan Tian, Jiyeon J Park, Gee Y (Geeny) Kim, Emily Aboujaoude & Marc G Sturgill. (2021) Management of chimeric antigen receptor T-cell induced cytokine release syndrome: Current and emerging approaches. Journal of Oncology Pharmacy Practice 28:1, pages 159-174.
Crossref
Crossref
Omran Saifi, William G. Breen, Scott C. Lester, William G. Rule, Bradley Stish, Allison Rosenthal, Javier Munoz, Steven M. Herchko, Hemant S. Murthy, Yi Lin, Radhika Bansal, Matthew A. Hathcock, N. Nora Bennani, Jonas Paludo, Yucai Wang, Arushi Khurana, Jose C. Villasboas Bisneto, Patrick B. Johnston, Stephen M. Ansell, Madiha Iqbal, Han Tun, Ernesto Ayala, Mohamed A. Kharfan-Dabaja, Bradford S. Hoppe & Jennifer L. Peterson. (2022) Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?. Radiotherapy and Oncology 166, pages 171-179.
Crossref
Crossref
Mehran Ghasemzadeh, Alireza Ghasemzadeh & Ehteramolsadat Hosseini. (2022) Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice. Human Immunology 83:1, pages 86-98.
Crossref
Crossref
Shane S. Scott, Ashley N. Greenlee, Ethan J. Schwendeman, Somayya J. Mohammad, Michael T. Naughton, Anna Matzko, Mamadou Diallo, Matthew Stein, Rohith Revan, Taborah Z. Zaramo, Gabriel Shimmin, Shwetabh Tarun, Joel Ferrall, Thai H. Ho & Sakima A. Smith. 2022. Cardiovascular Signaling in Health and Disease. Cardiovascular Signaling in Health and Disease
111
173
.
Diana C. DeLucia & John K. Lee. 2022. Cancer Immunotherapies. Cancer Immunotherapies
1
48
.
Bruktawit Maru, Lea Nadeau & Maureen McKeague. (2021) Enhancing CAR-T Cell Therapy with Functional Nucleic Acids. ACS Pharmacology & Translational Science 4:6, pages 1716-1727.
Crossref
Crossref
László Gopcsa, Ilona Bobek, Gabriella Bekő, Botond Lakatos, Eszter Molnár, Marienn Réti, Péter Reményi, János Sinkó, János Szlávik, Gábor Tatai & István Vályi-Nagy. (2021) Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome. Acta Microbiologica et Immunologica Hungarica 68:4, pages 240-255.
Crossref
Crossref
Lily Chan, Negar Karimi, Solmaz Morovati, Kasra Alizadeh, Julia E. Kakish, Sierra Vanderkamp, Fatemeh Fazel, Christina Napoleoni, Kimia Alizadeh, Yeganeh Mehrani, Jessica A. Minott, Byram W. Bridle & Khalil Karimi. (2021) The Roles of Neutrophils in Cytokine Storms. Viruses 13:11, pages 2318.
Crossref
Crossref
Arthur J. Van De Vyver, Estelle Marrer-Berger, Ken Wang, Thorsten Lehr & Antje-Christine Walz. (2021) Cytokine Release Syndrome By T-cell–Redirecting Therapies: Can We Predict and Modulate Patient Risk?. Clinical Cancer Research 27:22, pages 6083-6094.
Crossref
Crossref
Tor Henrik Anderson Tvedt, Anh Khoi Vo, Øystein Bruserud & Håkon Reikvam. (2021) Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences. Journal of Clinical Medicine 10:21, pages 5190.
Crossref
Crossref
Theodore W. Laetsch, Gregory A. Yanik, Michael W. Boyer & Susan R. Rheingold. (2021) An owner's manual for CD19 “CAR”-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia. Blood Reviews 50, pages 100848.
Crossref
Crossref
Georg von Massow, Steve Oh, Alan Lam & Kenth Gustafsson. (2021) Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections. Frontiers in Immunology 12.
Crossref
Crossref
Wenyan Cai, Jianbo Dong, Sachith Gallolu Kankanamalage, Allison Titong, Jiadong Shi, Zhejun Jia, Bo Wang, Cai Huang, Jing Zhang, Jun Lin, Steven Z Kan, Shuhua Han, Joe Zhou & Yue Liu. (2021) Biological activity validation of a computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action. Antibody Therapeutics 4:4, pages 228-241.
Crossref
Crossref
Katie L. Collins, Usir S. Younis, Sasipa Tanyaratsrisakul, Robin Polt, Meredith Hay, Heidi M. Mansour & Julie G. Ledford. (2021) Angiotensin-(1–7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice. Pharmaceutics 13:10, pages 1614.
Crossref
Crossref
Anat Aharon, Galit HornTali Hana Bar-LevEinav Zagagi YohayTova WaksMaya Levin, Naamit Deshet UngerIrit AviviAnat Globerson Levin. (2021) Extracellular Vesicles Derived from Chimeric Antigen Receptor-T Cells: A Potential Therapy for Cancer. Human Gene Therapy 32:19-20, pages 1224-1241.
Crossref
Crossref
Yingjuan J. Lu, Leroy W. WheelerIIII, Haiyan Chu, Paul J. Kleindl, Michael Pugh, Fei You, Satish Rao, Gabriela Garcia, Henry Y. Wu, Andre P. da Cunha, Richard Johnson, Elaine Westrick, Vicky Cross, Alex Lloyd, Christina Dircksen, Patrick J. Klein, Iontcho R. Vlahov, Philip S. Low & Christopher P. Leamon. (2021) Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes. Cell Reports Medicine 2:10, pages 100422.
Crossref
Crossref
Islam H. Elrobaa & Karl J. New. (2021) COVID-19: Pulmonary and Extra Pulmonary Manifestations. Frontiers in Public Health 9.
Crossref
Crossref
Mohsin Majeed & Tayyaba Noor. (2021) The Extrapulmonary Manifestations of SARS-CoV-2. The Open COVID Journal 1:1, pages 80-92.
Crossref
Crossref
Prashil Dave, Elisa Pallares Vela & Ivan Cancarevic. (2021) Is Prophylaxis the Only Way Out for Cytokine Release Syndrome Associated With Chimeric Antigen T-cell Therapy?. Cureus.
Crossref
Crossref
Giuliana Giardino, Roberta Romano, Emma Coppola, Francesca Cillo, Carla Borzachiello, Martina De Luca, Loredana Palamaro, Elisabetta Toriello, Rosaria Prencipe, Emilia Cirillo & Claudio Pignata. (2021) SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways. The Journal of Allergy and Clinical Immunology: In Practice 9:9, pages 3237-3248.
Crossref
Crossref
Clément V Normand, Hervé O Zender, Dominique M Staehli, Amina Faiza Chouiter-Djebaili & Gregor John. (2020) Acute cytokine release syndrome after a first dose of pembrolizumab as second-line treatment for metastatic, programmed death-ligand 1-positive, non-small-cell lung cancer. Journal of Oncology Pharmacy Practice 27:6, pages 1528-1533.
Crossref
Crossref
Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Wolfgang Marx, Adrienne O'Neil, Eugene Athan, Ken Walder, Michael Berk, Lisa Olive, Andre F. Carvalho & Michael Maes. (2021) The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?. Cytokine 144, pages 155593.
Crossref
Crossref
Rahul Banerjee, Jeffrey Marsal, Chiung-Yu Huang, Mimi Lo, Swetha Kambhampati, Vanessa E. Kennedy, Shagun Arora, Jeffrey L. Wolf, Thomas G. Martin, Sandy W. Wong & Nina Shah. (2021) Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplantation and Cellular Therapy 27:6, pages 477.e1-477.e7.
Crossref
Crossref
Tamara Rubilar, Elena S. Barbieri, Ayelén Gazquez & Marisa Avaro. (2021) Sea Urchin Pigments: Echinochrome A and Its Potential Implication in the Cytokine Storm Syndrome. Marine Drugs 19:5, pages 267.
Crossref
Crossref
Ross Salvaris, Jeremy Ong & Gareth P. Gregory. (2021) Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas. Journal of Personalized Medicine 11:5, pages 355.
Crossref
Crossref
Ethan A. Burns, Cesar Gentille, Barry Trachtenberg, Sai Ravi Pingali & Kartik Anand. (2021) Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management. Diseases 9:1, pages 20.
Crossref
Crossref
Maria de Miguel, Pablo Umana, Ana Luiza Gomes de Morais, Victor Moreno & Emiliano Calvo. (2021) T-cell–engaging Therapy for Solid Tumors. Clinical Cancer Research 27:6, pages 1595-1603.
Crossref
Crossref
Y.‐M. Gao, G. Xu, B. Wang & B.‐C. Liu. (2020) Cytokine storm syndrome in coronavirus disease 2019: A narrative review. Journal of Internal Medicine 289:2, pages 147-161.
Crossref
Crossref
Giovanni Garau, Sabrina Joachim, Guy‐Loup Duliere, Maria Melissopoulou, Sandrine Boccar, Vincent Fraipont, Christophe Dugauquier, Pierre Troisfontaines, Olivier Hougrand, Philippe Delvenne & Etienne Hoffer. (2020) Sudden cardiogenic shock mimicking fulminant myocarditis in a surviving teenager affected by severe acute respiratory syndrome coronavirus 2 infection. ESC Heart Failure 8:1, pages 766-773.
Crossref
Crossref
Mai M. Zafer, Hadir A. El-Mahallawy & Hossam M. Ashour. (2021) Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers. Microorganisms 9:1, pages 159.
Crossref
Crossref
Juliana Carvalho Santos, Marcelo Lima Ribeiro & Alessandra Gambero. (2021) The Impact of Polyphenols-Based Diet on the Inflammatory Profile in COVID-19 Elderly and Obese Patients. Frontiers in Physiology 11.
Crossref
Crossref
M. Eltahir, E. Fletcher, L. Dynesius, J.L. Jarblad, M. Lord, I. Laurén, M. Zekarias, X. Yu, M.S. Cragg, C. Hammarström, K.H. Levedahl, M. Höglund, G. Ullenhag, M. Mattsson & S.M. Mangsbo. (2021) Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients. International Immunopharmacology 90, pages 107226.
Crossref
Crossref
Stephanie Feldman, Kristine Jang, Dylana Smith & Robert S. Copeland-Halperin. 2021. Atlas of Imaging in Cardio-Oncology. Atlas of Imaging in Cardio-Oncology
291
306
.
Sebastian Bruera & Cerena K. Leung. 2021. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
255
269
.
Thomas R. Spitzer. (2020) Cytokine syndromes associated with hematopoietic cellular therapy. ADVANCES IN CELL AND GENE THERAPY 4:1.
Crossref
Crossref
Yu Zhang, Xin-yuan Guan & Peng Jiang. (2020) Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors. Frontiers in Immunology 11.
Crossref
Crossref
Utkarsh H. Acharya & Roland B. Walter. (2020) Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML). Cancers 12:12, pages 3617.
Crossref
Crossref
Norbert Lukan. (2020) “Cytokine storm”, not only in COVID-19 patients. Mini-review. Immunology Letters 228, pages 38-44.
Crossref
Crossref
Andrew Tsai, Oumou Diawara, Ronald G. Nahass & Luigi Brunetti. (2020) Impact of tocilizumab administration on mortality in severe COVID-19. Scientific Reports 10:1.
Crossref
Crossref
Luana Heimfarth, Mairim Russo Serafini, Paulo Ricardo Martins-Filho, Jullyana de Souza Siqueira Quintans & Lucindo José Quintans-Júnior. (2020) Drug repurposing and cytokine management in response to COVID-19: A review. International Immunopharmacology 88, pages 106947.
Crossref
Crossref
Ling Li, Zhen Yang & Xiaoyuan Chen. (2020) Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy. Accounts of Chemical Research 53:10, pages 2044-2054.
Crossref
Crossref
Vladimir Petrovic, Dina Radenkovic, Goran Radenkovic, Vukica Djordjevic & Maciej Banach. (2020) Pathophysiology of Cardiovascular Complications in COVID-19. Frontiers in Physiology 11.
Crossref
Crossref
Daria Fomina, Mar’yana A. Lysenko, Irina P. Beloglazova, Zinaida Yu. Mutovina, Nataliya G. Poteshkina, Inna V. Samsonova, Tat’yana S. Kruglova, Anton A. Chernov & Alexander V. Karaulov. (2020) Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia. Pathogens and Immunity 5:1, pages 327.
Crossref
Crossref
Chunting Ye, Hongyuan Yang, Mingshan Cheng, Leonard D. Shultz, Dale L. Greiner, Michael A. Brehm & James G. Keck. (2020) A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic‐related cytokine release syndrome. The FASEB Journal 34:9, pages 12963-12975.
Crossref
Crossref
Jie Zhao, Xiaodong Yang, Chenghua Wang, Shuai Song, Kun Cao, Taohua Wei, Qiaoxue Ji, Wanqun Zheng, Jiali Li, Xue Zhou & Jie Liu. (2020) Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a. Biomedicine & Pharmacotherapy 129, pages 110436.
Crossref
Crossref
Arno R Bourgonje, Amaal E Abdulle, Wim Timens, Jan‐Luuk Hillebrands, Gerjan J Navis, Sanne J Gordijn, Marieke C Bolling, Gerard Dijkstra, Adriaan A Voors, Albert DME Osterhaus, Peter HJ Voort, Douwe J Mulder & Harry Goor. (2020)
Angiotensin‐converting enzyme 2 (
ACE2
),
SARS‐CoV
‐2 and the pathophysiology of coronavirus disease 2019 (
COVID
‐19)
. The Journal of Pathology 251:3, pages 228-248.
Crossref
Crossref
Rafael B. Polidoro, Robert S. Hagan, Roberta de Santis Santiago & Nathan W. Schmidt. (2020) Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Frontiers in Immunology 11.
Crossref
Crossref
Tracey L. Freeman & Talia H. Swartz. (2020) Targeting the NLRP3 Inflammasome in Severe COVID-19. Frontiers in Immunology 11.
Crossref
Crossref
Marisa Market, Leonard Angka, Andre B. Martel, Donald Bastin, Oladunni Olanubi, Gayashan Tennakoon, Dominique M. Boucher, Juliana Ng, Michele Ardolino & Rebecca C. Auer. (2020) Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies. Frontiers in Immunology 11.
Crossref
Crossref
Leyla S. Namazova-Baranova, Nikolay N. Murashkin & Roman A. Ivanov. (2020) Biological Therapy During COVID-19. Current Pediatrics 19:2, pages 116-122.
Crossref
Crossref
Omran Saifi, Mohamed A. Kharfan-Dabaja, Youssef H. Zeidan, Jennifer Peterson, William G. Rule, Scott C. Lester & Bradford S. Hoppe. (2020) Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?. International Journal of Particle Therapy 7:1, pages 13-20.
Crossref
Crossref
Andrea Picchianti Diamanti, Maria Manuela Rosado, Claudio Pioli, Giorgio Sesti & Bruno Laganà. (2020) Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. International Journal of Molecular Sciences 21:9, pages 3330.
Crossref
Crossref
Alessia Alunno, Francesco Carubbi & Javier Rodríguez-Carrio. (2020) Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. RMD Open 6:1, pages e001295.
Crossref
Crossref
Catalin Constantinescu, Sergiu Pasca, Tiberiu Tat, Patric Teodorescu, Catalin Vlad, Sabina Iluta, Delia Dima, Dana Tomescu, Ecaterina Scarlatescu, Alina Tanase, Olafur Eysteinn Sigurjonsson, Anca Colita, Hermann Einsele & Ciprian Tomuleasa. (2020) Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?. Journal for ImmunoTherapy of Cancer 8:1, pages e000742.
Crossref
Crossref
Jingyu Wang, Fang Shen, Ying Yao, Lin-lin Wang, Yongjian Zhu & Jue Hu. (2020) Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma. Frontiers in Oncology 10.
Crossref
Crossref